首页> 美国卫生研究院文献>BMC Pregnancy and Childbirth >A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
【2h】

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia

机译:一项横断面研究评估先兆子痫和不先兆子痫的孕妇中sFlt-1:PlGF的比率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPreeclampsia is a multisystem disorder characterized by vascular endothelial malfunction occurring after 20 weeks of gestation. Placental soluble fms-like tyrosine kinase-1 (sFlt-1) is an antiangiogenic factor and placental growth factor (PlGF) is a potent angiogenic factor. The imbalance between these factors during placenta and fetal development has been shown to play a role in endothelial damage in preeclampsia.Preeclampsia is the leading cause of maternal mortality in Nepal. This study was designed to compare the sFlt1:PLGF ratio in pregnant women with and without preeclampsia attending Tribhuvan University Teaching Hospital (TUTH).
机译:背景先兆子痫是一种多系统疾病,其特征在于妊娠20周后发生血管内皮功能衰竭。胎盘可溶性fms样酪氨酸激酶1(sFlt-1)是抗血管生成因子,胎盘生长因子(PlGF)是有效的血管生成因子。已证明子痫前期这些因子在胎盘和胎儿发育过程中的失衡是内皮损伤的原因。子痫前期是尼泊尔孕产妇死亡的主要原因。本研究旨在比较特里布万大学教学医院(TUTH)有先兆子痫和没有先兆子痫的孕妇中sFlt1:PLGF的比率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号